Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Studied exclusively in preclinical animal models in the context of gut, joint, connective tissue, and inflammatory processes.* 1-8
Starting even lower and escalating even more gradually should theoretically produce even fewer symptoms, at the cost of a longer time to reach therapeutic levels
Traditional antibiotic treatments face limitations, including the development of resistance, disruption of the microbiota, adverse side effects, and environmental impact, emphasizing the urgent need for innovative alternative antibacterial strategies
J Aging Res Clin Pract
Salaga M, Binienda A, Draczkowski P, Kosson P, Kordek R, Jozwiak K, Fichna J (2018) Novel peptide inhibitor of dipeptidyl peptidase IV (Tyr-Pro-D-Ala-NH2) with anti-inflammatory activity in the mouse models of colitis
US$ 25.84
US$ 26.86
US$ 24.09
US$ 27.22
.png)
US$ 24.86
